These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34965724)

  • 1. PPAR-α Agonist GW7647 Protects Against Oxidative Stress and Iron Deposit via GPx4 in a Transgenic Mouse Model of Alzheimer's Diseases.
    Qu XX; He JH; Cui ZQ; Yang T; Sun XH
    ACS Chem Neurosci; 2022 Jan; 13(2):207-216. PubMed ID: 34965724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPAR-α agonist regulates amyloid-β generation via inhibiting BACE-1 activity in human neuroblastoma SH-SY5Y cells transfected with APPswe gene.
    Zhang H; Gao Y; Qiao PF; Zhao FL; Yan Y
    Mol Cell Biochem; 2015 Oct; 408(1-2):37-46. PubMed ID: 26092426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenofibrate reduces amyloidogenic processing of APP in APP/PS1 transgenic mice via PPAR-α/PI3-K pathway.
    Zhang H; Gao Y; Qiao PF; Zhao FL; Yan Y
    Int J Dev Neurosci; 2014 Nov; 38():223-31. PubMed ID: 25447788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydroxy stilbene glycoside ameliorates Alzheimer's disease in APP/PS1 mice via glutathione peroxidase related ferroptosis.
    Gao Y; Li J; Wu Q; Wang S; Yang S; Li X; Chen N; Li L; Zhang L
    Int Immunopharmacol; 2021 Oct; 99():108002. PubMed ID: 34333354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocyte hepcidin ameliorates neuronal loss through attenuating brain iron deposition and oxidative stress in APP/PS1 mice.
    Xu Y; Zhang Y; Zhang JH; Han K; Zhang X; Bai X; You LH; Yu P; Shi Z; Chang YZ; Gao G
    Free Radic Biol Med; 2020 Oct; 158():84-95. PubMed ID: 32707154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyanidin 3-O-β-glucopyranoside activates peroxisome proliferator-activated receptor-γ and alleviates cognitive impairment in the APP(swe)/PS1(ΔE9) mouse model.
    Song N; Zhang L; Chen W; Zhu H; Deng W; Han Y; Guo J; Qin C
    Biochim Biophys Acta; 2016 Sep; 1862(9):1786-800. PubMed ID: 27240542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial aldehyde dehydrogenase (ALDH2) rescues cardiac contractile dysfunction in an APP/PS1 murine model of Alzheimer's disease via inhibition of ACSL4-dependent ferroptosis.
    Zhu ZY; Liu YD; Gong Y; Jin W; Topchiy E; Turdi S; Gao YF; Culver B; Wang SY; Ge W; Zha WL; Ren J; Pei ZH; Qin X
    Acta Pharmacol Sin; 2022 Jan; 43(1):39-49. PubMed ID: 33767380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer's Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist.
    Chang KL; Wong LR; Pee HN; Yang S; Ho PC
    Mol Neurobiol; 2019 Nov; 56(11):7267-7283. PubMed ID: 31016475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Effect of Notoginsenoside R1 on an APP/PS1 Mouse Model of Alzheimer's Disease by Up-Regulating Insulin Degrading Enzyme and Inhibiting Aβ Accumulation.
    Li Z; Li H; Zhao C; Lv C; Zhong C; Xin W; Zhang W
    CNS Neurol Disord Drug Targets; 2015; 14(3):360-9. PubMed ID: 25714973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease.
    Paris D; Ganey NJ; Laporte V; Patel NS; Beaulieu-Abdelahad D; Bachmeier C; March A; Ait-Ghezala G; Mullan MJ
    J Neuroinflammation; 2010 Mar; 7():17. PubMed ID: 20211007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.
    Ettcheto M; Petrov D; Pedrós I; Alva N; Carbonell T; Beas-Zarate C; Pallas M; Auladell C; Folch J; Camins A
    J Alzheimers Dis; 2016 Jul; 54(1):233-51. PubMed ID: 27567882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of the effects of phosphatidylcholine rich in DHA and EPA on Alzheimer's disease and the possible mechanisms in CHO-APP/PS1 cells and SAMP8 mice.
    Che H; Zhou M; Zhang T; Zhang L; Ding L; Yanagita T; Xu J; Xue C; Wang Y
    Food Funct; 2018 Jan; 9(1):643-654. PubMed ID: 29292421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
    Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
    Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β‑asarone modulates Beclin‑1, LC3 and p62 expression to attenuate Aβ40 and Aβ42 levels in APP/PS1 transgenic mice with Alzheimer's disease.
    Deng M; Huang L; Zhong X
    Mol Med Rep; 2020 May; 21(5):2095-2102. PubMed ID: 32186763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron accumulation in microglia triggers a cascade of events that leads to altered metabolism and compromised function in APP/PS1 mice.
    McIntosh A; Mela V; Harty C; Minogue AM; Costello DA; Kerskens C; Lynch MA
    Brain Pathol; 2019 Sep; 29(5):606-621. PubMed ID: 30661261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-PPAR modulation effectively protects APP/PS1 mice from amyloid deposition and cognitive deficits.
    Kummer MP; Schwarzenberger R; Sayah-Jeanne S; Dubernet M; Walczak R; Hum DW; Schwartz S; Axt D; Heneka MT
    Mol Neurobiol; 2015 Apr; 51(2):661-71. PubMed ID: 24838579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Multitarget Directed Tacrine Hybrids as Anti-Alzheimer's Compounds Improved Synaptic Plasticity and Cognitive Impairment in APP/PS1 Transgenic Mice.
    Li K; Jiang Y; Li G; Liu T; Yang Z
    ACS Chem Neurosci; 2020 Dec; 11(24):4316-4328. PubMed ID: 33216529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
    J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.
    Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS
    Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
    Liu HL; Zhao G; Zhang H; Shi LD
    Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.